Clinical trial
COMPASS-PedPCOS: BMI-Independent Mechanistic Dissection of PCOS-Associated MASLD in Adolescent Girls With Obesity Using an Expanded Biomarker Panel - A Single-Center Pre-Pilot Clinical Study
NCT07731373 is registered in ClinicalTrials.gov with Kayseri City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COMPASS-PedPCOS: BMI-Independent Mechanistic Dissection of PCOS-Associated MASLD in Adolescent Girls With Obesity Using an Expanded Biomarker Panel - A Single-Center Pre-Pilot Clinical Study
- Lead sponsor
- Kayseri City Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- September 1, 2027
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperandrogenism, insulin resistance syndrome, metabolic dysfunction-associated steatotic liver disease, pediatric obesity, polycystic ovary syndrome (pcos)